The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide

Neuron

Volumn 39, Issue 1, 2003, Pages 43-56

  Soucek, Thomas ^a   Cumming, Robert ^a   Dargusch, Richard ^a   Maher, Pamela ^b   Schubert, David ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CLOZAPINE; FLUPHENAZINE; GLUCOSE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOLYTIC ENZYME; HEXOKINASE; HEXOSE PHOSPHATE; HYPOXIA INDUCIBLE FACTOR 1; NEUROLEPTIC AGENT; PYRUVATE KINASE;

AGE; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL CLONING; CELL KILLING; CELL LINE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; HYPOGLYCEMIA; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

EID: 0038644221     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(03)00367-2     Document Type: Article

References (62)

1. Ardizzone T.D., Bradley R.J., Freeman A.M. III, Dwyer D.S. Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine. Brain Res. 923:2001;82-90.
2. Ashcroft S.J.H., Weerasinghe L.C.C., Bassett J.M., Randle P.J. The pentose cycle and insulin release in mouse pancreatic islets. Biochem. J. 126:1972;525-532.
3. Behl C., Schubert D. Heat shock partially protects rat pheochromocytoma PC12 cells from amyloid β peptide toxicity. Neurosci. Lett. 154:1993;1-4.
4. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell. 77:1994;817-827.
5. Bernaudin M., Tang Y., Reilly M., Petit E., Sharp F.R. Brain genomic response following hypoxia and re-oxygenation in the neonatal rat. J. Biol. Chem. 277:2002;39728-39738.
6. Blass J.P. Brain metabolism and brain disease. is metabolic deficiency the proximate cause of Alzheimer dementia? J. Neurosci. Res. 66:2001;851-856.
7. Bowen D.M., White P., Spillane J.A., Goodhardt M.J., Curzon G., Iwangoff P., Meier-Ruge W., Davison A.N. Accelerated ageing or selective neuronal loss as an important cause of dementia. Lancet. i:1979;11-14.
8. Brand K. Aerobic glycolysis by proliferating cells. J. Bioenerg. Biomembr. 29:1997;355-364.
9. Cherny R.A., Atwood C.S., Xilinas M.E., Gray D.N., Jones W.D., McLean C.A., Barnham K.J., Volitakis I., Fraser F.W., Kim Y.et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron. 30:2001;641-642.
10. Craft S., Newcomer J., Kanne S., Dagogo-Jack S., Cryer P., Sheline Y., Luby J., Dagogo-Jack A., Alderson A. Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiol. Aging. 17:1996;123-130.
11. Dargusch R., Schubert D. Specificity of resistance to oxidative stress. J. Neurochem. 81:2002;1394-1400.
12. Drutel G., Kathmann M., Heron A., Gros C., Mace S., Schwartz H.C., Arrang J.M. Two splice variants of the hypoxia-inducible factor HIF-1α as potential dimerization partners of ARNT2 in neurons. Eur. J. Neurosci. 12:2000;3701-3708.
13. Dufour E., Boulay J., Rincheval V., Sainsard-Chanet A. A causal link between respiration and senescence in Podospora anserina. Proc. Natl. Acad. Sci. USA. 97:2000;4138-4143.
14. Duyndam M.C., Hulscher T.M., Fontijn D., Pinedo H.M., Boven E. Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1alpha protein by the oxidative stressor arsenite. J. Biol. Chem. 276:2001;48066-48076.
15. Dwyer D.S., Pinkofsky H.B., Liu Y., Bradley R.J. Antipsychotic drugs affect glucose uptake and the expression of glucose transporters in PC12 cells. Prog. Neuropsychopharmacol. Biol. Psychiatry. 23:1999;69-80.
16. Esmann V. Regulatory Mechanisms of Carbohydrate Metabolism. 1978;Pergamon Press, New York.
17. Gibson G.E. Interactions of oxidative stress with cellular calcium dynamics and glucose metabolism in Alzheimer's disease. Free Radic. Biol. Med. 32:2002;1061-1070.
18. Hiles B.W. Hyperglycemia and glycosuria following chlorpromazine therapy. JAMA. 162:1956;1651.
19. Honegger P., Braissant O., Henry H., Boulat O., Bachmann C., Zurich M.-G., Pardo B. Alteration of amino acid metabolism in neuronal aggregate cultures exposed to hypoglycaemic conditions. J. Neurochem. 81:2002;1141-1151.
20. Horwood N., Davies D.C. Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease. Virchows Arch. 425:1994;69-72.
21. Hyslop P.A., Hinshaw D.B., Halsey W.A. Jr., Schraufstatter I.U., Sauerhebet R.D., Spragg R.G., Jackson J.H., Cochrane C.G. Mechanisms of oxidant-mediated cell injury. J. Biol. Chem. 263:1988;1665-1675.
22. Katschinski D.M., Le L., Heinrich D., Wagner K.F., Hofer T., Schindler S.G., Wenger R.H. Heat induction of the unphosphorylated form of hypoxia-inducible factor-1α is dependent on heat shock protein-90 activity. J. Biol. Chem. 277:2002;9262-9267.
23. Kaur D., Yantiri F., Rajagopalan S., Kumar J., Mo J.Q., Boonplueang R., Viswanath V., Jacobs R., Yang L., Beal M.F.et al. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo. A novel therapy for Parkinson's disease Neuron. 37:2003;899-909.
24. Klein W.L., Krafft G.A., Finch C.E. Targeting small Abeta oligomers. the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24:2001;219-224.
25. Li Y., Maher P., Schubert D. A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron. 19:1997;453-463.
26. Lim G.P., Chu T., Yang F., Beech W., Frautschy S.A., Cole G.M. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 21:2001;8370-8377.
27. Lin S.-J., Kaeberlein M., Andalis A.A., Sturtz L.A., Defossez P.-A., Culotta V.C., Fink G.R., Guarente L. Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration. Nature. 418:2002;344-348.
28. Liu Y., Peterson D.A., Kimura H., Schubert D. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 69:1997;581-593.
29. Maher F., Davies-Hill T.M., Lysko P.G., Henneberry R.C., Simpson I.A. Expression of two glucose transporters, GLUT1 and GLUT3 in cultured cerebellar cells. Mol. Cell. Neurosci. 2:1991;351-360.
30. Manning C.A., Ragozzino M.E., Gold P.E. Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer's type. Neurobiol. Aging. 14:1993;523-528.
31. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., Wykoff C.C., Pugh C.W., Maher E.R., Ratcliffe P.J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 399:1999;203-204.
32. McLachlan D.R.C., Kruck T.P., Lukiw W.J., Krishnan S.S. Would decreased aluminum ingestion reduce the incidence of Alzheimer's disease? Can. Med. Assoc. J. 145:1991;793-804.
33. Michiels C., Minet E., Mottet D., Raes M. Regulation of gene expression by oxygen. NF-κB and HIF-1, two extremes Free Radic. Biol. Med. 33:2002;1231-1242.
34. Mielke R., Herholz K., Grond M., Kessler J., Heiss W.D. Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type. Neurobiol. Aging. 13:1991;93-98.
35. Ott A., Stolk R.P., van Harskamp F., Pols H.A., Hofman A., Bretele R.M.M. Diabetes mellitus and the risk of dementia. the Rotterdam study Neurology. 53:1999;1937-1942.
36. Palmer A.M. The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease. J. Neural Transm. 106:1999;317-328.
37. Parpura-Gill A., Beitz D., Uemura E. The inhibitory effects of β-amyloid on glutamate and glucose uptakes by cultured astrocytes. Brain Res. 754:1997;65-71.
38. Piret J.P., Mottet D., Raes M., Michiels C. Is HIF-1alpha a pro- or an anti-apoptotic protein? Biochem. Pharmacol. 64:2002;889-892.
39. Russell R.L., Siedlak S.L., Raina A.K., Bautista J.M., Smith M.A., Perry G. Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease. Arch. Biochem. Biophys. 370:1999;236-239.
40. Sagara Y., Dargusch R., Klier F.G., Schubert D., Behl C. Increased antioxidant enzyme activity in amyloid beta protein-resistant cells. J. Neurosci. 16:1996;497-505.
41. Salvemini F., Franze A., Iervolino A., Filosa S., Salzano S., Ursini M.V. Enhanced glutathione levels and oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression. J. Biol. Chem. 274:1999;2750-2757.
42. Schubert D., Chevion M. The role of iron in beta amyloid toxicity. Biochem. Biophys. Res. Commun. 216:1995;702-707.
43. Schulingkamp R.J., Pagano T.C., Hung D., Raffa R.B. Insulin receptors and insulin action in the brain. review and clinical implications Neurosci. Biobehav. Rev. 24:2000;855-872.
44. Schwartz M., Duara R., Haxby J., Grady C., White B.J., Kessler R.M., Kay A.D., Cutler N.R., Rapoport S.I. Down's syndrome in adults. brain metabolism Science. 221:1983;781-783.
45. Semenza G.L. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15:1999;551-578.
46. 14C]glucose by tissue prisms from human neocortex. Biochem. J. 196:1981;867-876.
47. 14C]glucose in vitro in human neocortex J. Neurochem. 41:1983;1329-1334.
48. Sims N.R., Finegan J.M., Blass J.P., Bowen D.M., Neary D. Mitochondrial function in brain tissue in primary degenerative dementia. Brain Res. 436:1987;30-38.
49. Smith M.A., Harris P.L.R., Sayre L.M., Beckman J.S., Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's Disease. J. Neurosci. 17:1997;2653-2657.
50. Srinivas V., Zhang L., Shu X., Caro J. Characterization of an oxygen/redox-dependent degradation domain of hypoxia-inducible factor alpha (HIF-a) proteins. Biochem. Biophys. Res. Commun. 260:1999;557-561.
51. Strohman R. Maneuvering in the complex path from genotype to phenotype. Science. 296:2002;701-703.
52. Tan S., Somia N., Maher P., Schubert D. Regulation of antioxidant metabolism by translation initiation factor-2 alpha. J. Cell Biol. 152:2001;997-1006.
53. Terry R.D. Cell death or synaptic loss in Alzheimer disease. J. Neuropathol. Exp. Neurol. 59:2000;1118-1119.
54. Terry R.D., Masliah E., Hansen L.A. Structural basis of the cognitive alterations in Alzheimer disease. Terry R.D., Katzman R., Bick K.L. Alzheimer Disease. 1994;Raven Press, New York. 179-196.pp.
55. Thonnard-Neumann E. Phenothiazines and diabetes in hospitalized women. Am. J. Psychiatry. 124:1968;978-982.
56. Wang G.L., Jiang B.H., Rue E.A., Semenza G.L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA. 92:1995;5510-5514.
57. Webster K.A., Gunning P., Hardeman E., Wallace D.C., Kedes L. Coordinate reciprocal trends in glycolytic and mitochondrial transcript accumulations during the in vitro differentiation of human myoblasts. J. Cell. Physiol. 142:1990;566-573.
58. Wisniewski K.E., Dalton A.J., McLachlan C., Wen G.Y., Wisniewski H.M. Alzheimer's disease in Down's syndrome. clinicopathological studies Neurology. 35:1985;957-961.
59. Wong W.L., Brostrom M.A., Kuznetsov G., Gmitter-Yellen D., Brostrom C.O. Inhibition of protein synthesis and early protein processing by thapsigargin in cultured cells. Biochem. J. 289:1993;71-79.
60. Worthington C. Worthington Enzyme Manual. 1947;Worthington Biochemical Corporation, Freehold, NJ.
61. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid beta protein. reversal by tachykinin neuropeptides Science. 250:1990;279-282.
62. Zhang Z., Yu J., Stanton R.C. A method for determination of pyridine nucleotides using a single extract. Anal. Biochem. 285:2000;163-167.